tiprankstipranks
Sona Nanotech Advances Cancer Treatment Tech
Company Announcements

Sona Nanotech Advances Cancer Treatment Tech

Sona Nanotech, Inc (TSE:SONA) has released an update.

Don't Miss Our Christmas Offers:

Sona Nanotech Inc. has filed a provisional patent for a new photothermal light medical device designed to work with their gold nanorods for efficient cancer treatment. The device is undergoing a pre-clinical study at Dalhousie University and has garnered positive feedback from both the FDA and a panel of leading U.S. surgeons. Additionally, the company has strengthened its Advisory Board with the appointment of Dr. Carman Giacomantonio, a surgical oncologist involved in the current study.

For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Reports Promising Cancer Therapy Results
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Advances Cancer Therapy Research
TipRanks Canadian Auto-Generated NewsdeskSona Nanotech Secures Patent and Strengthens Leadership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App